The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer

Immunotherapies targeting truly tumor-specific targets focus on the expansion and activation of T cells against neoantigens or oncogenic viruses. One target is the human papilloma virus type 16 (HPV16), responsible for several anogenital cancers and oropharyngeal carcinomas. Spontaneous and vaccine-...

Descripción completa

Detalles Bibliográficos
Autores principales: Santegoets, Saskia J., Welters, Marij J. P., Schrikkema, Deborah S., Freriks, Manon R., Kok, Hanna, Weissbrich, Bianca, van den Branden, Anouk, Linnemann, Carsten, Schumacher, Ton N., Adhikary, Sabina, Bendle, Gavin, van der Burg, Sjoerd H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198845/
https://www.ncbi.nlm.nih.gov/pubmed/36526910
http://dx.doi.org/10.1007/s00262-022-03350-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198845/
https://www.ncbi.nlm.nih.gov/pubmed/36526910
http://dx.doi.org/10.1007/s00262-022-03350-x

Ejemplares similares